About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 38152 record(s)
Req # A-2023-000194
All current Health Canada approved labelling and currently approved intended use for: Licence No.: 98062 BTL-6000 SUPER INDUCTIVE SYSTEM ELITE.Organization: Health Canada
July 2023
Req # A-2023-000364
The hospitals that requisitioned nicardipine in the years 2020, 2021, and 2022 via Health Canada‘s Special Access Program.Organization: Health Canada
July 2023
Req # A-2023-000380
The scientific evidence which allows 500mg of berberine and berberine hydrochloride will support the approved health claims to the effect of: Provides support for healthy glucose metabolism. Helps support healthy blood lipid levels. Helps support…Organization: Health Canada
July 2023
Req # A-2020-000843
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-109831-451.Organization: Health Canada
July 2023
Req # A-2020-000930
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-111487-77.Organization: Health Canada
July 2023
Req # A-2021-001139
Adverse Drug Reaction (ADR) for FLUDARABINE PHOSPHATE. Report number: E2B_03522367.Organization: Health Canada
July 2023
Req # A-2021-002058
Adverse Drug Reactions (ADRs). Report numbers: E2B_03833163, E2B_03711903, E2B_04785284, E2B_04793915.Organization: Health Canada
July 2023
Req # A-2022-000146
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-111407-100.Organization: Health Canada
July 2023
Req # A-2022-000220
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-111887-294.Organization: Health Canada
July 2023
Req # A-2022-000339
Adverse Drug Reaction (ADR) for ZOLEDRONIC ACID. Report number: 950981. ADR for CLONAZEPAM-R. Report number: 966705.Organization: Health Canada
July 2023